A photo of Jennifer Huggins.

Fellowship Program Director, Division of Rheumatology

Associate Professor, UC Department of Pediatrics


Board Certified

Make an Appointment

My Biography & Research


Dr. Huggins is board certified in pediatrics, internal medicine, allergy/immunology, pediatric and adult rheumatology. She was a primary care provider for internal medicine/pediatrics for 12 years before entering fellowship training for allergy/immunology/rheumatology. As a result of her primary care experience she is aware of the importance and complexities of vaccine administration. In addition to her responsibilities as the Pediatric Rheumatology Fellowship program director, she cares for a significant number of patients with juvenile idiopathic arthritis (JIA) as well as systemic lupus erythematosus (SLE) in the division. Her current caseload includes over 60% of the SLE patients at Cincinnati Children’s. Dr. Huggins has a Pfizer Grant to improve the administration of appropriate vaccinations in our Immunocompromised patients. This project builds logically on her previous primary care experience and current clinical work, and commitment to improving vaccination protection for immunocompromised patients.

Academic Affiliation

Associate Professor, UC Department of Pediatrics


Rheumatology, Lupus, Rheumatology

My Locations

My Education

MD: University of Kansas Medical School, Kansas City, KS.

Residency: Baylor College of Medicine, 1986.

Residency: University of Rochester School of Medicine, 1988.

Fellowship: Allergy/Immunology and Rheumatology, University of Rochester School of Medicine, 2005.

Fellowship: Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, 2007.

My Publications

American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. Brunner, HI; Holland, MJ; Beresford, MW; Ardoin, SP; Appenzeller, S; Silva, CA; Flores, F; Aydin, PO A; Wenderfer, SE; Levy, DM; et al. Arthritis Care and Research. 2019; 71:579-590.

Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing?. Harry, O; Crosby, LE; Smith, AW; Favier, L; Aljaberi, N; Ting, TV; Huggins, JL; Modi, AC. Lupus. 2019; 28:642-650.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Hinze, CH; Foell, D; Johnson, AL; Spalding, SJ; Gottlieb, BS; Morris, PW; Kimura, Y; Onel, K; Li, SC; Grom, AA; et al. Arthritis and Rheumatology. 2019; 71:451-459.

Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus. Holland, MJ; Beresford, MW; Feldman, BM; Huggins, J; Norambuena, X; Silva, CA; Susic, G; Sztajnbok, F; Uziel, Y; Appenzeller, S; et al. Arthritis Care and Research. 2018; 70:1621-1629.

Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus. Ale'Ed, A; Aydin, PO A; Al Mutairi, N; Alsaleem, A; Sonmez, HE; Henrickson, M; Huggins, JL; Ozen, S; Al-Mayouf, SM; Brunner, HI. Lupus Science and Medicine. 2018; 5:e000275-e000275.

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease. Lovell, DJ; Johnson, AL; Huang, B; Gottlieb, BS; Morris, PW; Kimura, Y; Onel, K; Li, SC; Grom, AA; Taylor, J; et al. Arthritis and Rheumatology. 2018; 70:1508-1518.

A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Patel, ZH; Lu, X; Miller, D; Forney, CR; Lee, J; Lynch, A; Schroeder, C; Parks, L; Magnusen, AF; Chen, X; et al. Human Molecular Genetics. 2018; 27:2392-2404.

Transancestral mapping and genetic load in systemic lupus erythematosus. Langefeld, CD; Ainsworth, HC; Graham, DS C; Kelly, JA; Comeau, ME; Marion, MC; Howard, TD; Ramos, PS; Croker, JA; Morris, DL; et al. Nature Communications. 2017; 8.

Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children's hospital. Jean, MR; Weaver, A; Mastin-Diebold, T; Kissinger, K; Smitherman, EA; Favier, L; Danziger-Isakov, L; Williams, E; Brady, RC; Huggins, J; et al. BMJ Open Quality. 2017; 6:e000092-e000092.

Improving health maintenance supervision in a paediatric IBD clinic. Dykes, DM H; Jean, MR; Morgan, P; Hill, D; Williams, E; Opipari-Arigan, L; Huggins, J; Saeed, SA. BMJ Open Quality. 2017; 6:e000012-e000012.